Market Overview:
The global sinus bradycardia market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of sinus bradycardia, rising geriatric population, and technological advancements in the field of medical devices. However, the high cost associated with treatment and lack of awareness about sinus bradycardia are some factors that may restrain the growth of this market during the forecast period. Based on type, the global sinus bradycardia market is segmented into atropine, isoproterenol, aminophylline, ephedrin, scopolamine pacemaker implantable cardioverter defibrillator (ICD). Based on application, it is segmented into sinus cardiac arrest (SCA), sinus atrial block (SAB),sinus node syndrome (SNS), other applications such as sick SinUS syndrome and junctional ectopic tachycardias etc.). Geographically it has been analyzed across North America Latin America Europe Asia Pacific and Middle East & Africa regions.
Product Definition:
A heart rate that is below 60 beats per minute is considered to be sinus bradycardia. This condition can be caused by various factors, such as age, medications, and health conditions. Sinus bradycardia may not cause any symptoms, but it can lead to a decrease in the amount of blood that is pumped out of the heart. This can reduce the amount of oxygen that reaches the rest of the body.
Atropine:
Atropine is a tropane alkaloid that was initially extracted from the deadly nightshade plant. It is now manufactured synthetically as well as naturally. Atropine sulfate, which is commercially available in both dry and liquid forms, has been used extensively in ophthalmic surgery and also for treatment of bronchospasm due to asthma.
The drug's mechanism of action remains unknown despite numerous research efforts being undertaken over the past few decades.
Isoproterenol:
Isoproterenol is a selective beta-1 adrenergic receptor agonist used in the treatment of severe heart failure and pulmonary hypertension. It is also used off label to treat sinus bradycardia.
Application Insights:
Sinus cardiac arrest held the largest share of over 50.0% in 2017. The increasing prevalence of heart diseases such as heart attack, cardiomyopathy and arrhythmia is contributing to the growth of this segment. For instance, according to a study published in NCBI, it was found that around 1 out of every 3 deaths occur due to cardiovascular disease globally. Moreover, another study states that around 2-3 million people die from CVDs annually worldwide and it accounts for about 70% - 80%of all deaths caused by Cardiovascular Diseases (CVDs). Thus, rising incidences related to these conditions are expected to boost sinus bradycardia market growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of cardiac arrests and growing geriatric population. In addition, rising awareness regarding advanced treatment options for heart diseases is also one of the major factors responsible for regional growth.
Asia Pacific is anticipated to be the fastest-growing region over the forecast period owing to a large patient pool and improving healthcare facilities in emerging economies such as India and China. Moreover, increasing medical tourism activities are also expected drive demand during this period. For instance, according to a study published by National Bureau of Economic Research (NBER), from 2014 till 2018, India has experienced an increase in medical tourists by 44%.
Moreover, favorable government initiatives pertaining Sinusitis care are projected towards quality healthcare services will further boost market development across Asia Pacific countries during this time frame (2018 - 2030).
Growth Factors:
- Increasing prevalence of sinus bradycardia
- Growing geriatric population
- Rising awareness about the condition and its treatment options
- Technological advancements in diagnosis and treatment of sinus bradycardia
- increasing number of clinical studies on sinus bradycardia
Scope Of The Report
Report Attributes
Report Details
Report Title
Sinus Bradycardia Market Research Report
By Type
Atropine, Isoproterenol, Aminophylline, Ephedrin, Scopolamine, Pacemaker, Implantable Cardioverter Defibrillator
By Application
Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other
By Companies
Abcam, Albany Molecular Research, Alchem International, Shree Pacetronix, Abbott Laboratories, Amgen, Livanova, C2 Pharma, CR Double-Crane, Fine Chemicals Corporation, Medtronic, Sorin Group, Biotronik, Nihon Kohden, Henry Schein, Hospira, Katsura Chemical, Luyin, Medarex, Merck, Boston Scientific, Nexus Pharmaceuticals, Pfizer, Phytex Australia, Oscor, ROLABO OUTSOURCING, Sanofi, Osypka Medical, Laboratoires Servier
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Sinus Bradycardia Market Report Segments:
The global Sinus Bradycardia market is segmented on the basis of:
Types
Atropine, Isoproterenol, Aminophylline, Ephedrin, Scopolamine, Pacemaker, Implantable Cardioverter Defibrillator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Sinus Cardiac arrest, Sinus Atrial Block, Sinus Node Syndrome, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Albany Molecular Research
- Alchem International
- Shree Pacetronix
- Abbott Laboratories
- Amgen
- Livanova
- C2 Pharma
- CR Double-Crane
- Fine Chemicals Corporation
- Medtronic
- Sorin Group
- Biotronik
- Nihon Kohden
- Henry Schein
- Hospira
- Katsura Chemical
- Luyin
- Medarex
- Merck
- Boston Scientific
- Nexus Pharmaceuticals
- Pfizer
- Phytex Australia
- Oscor
- ROLABO OUTSOURCING
- Sanofi
- Osypka Medical
- Laboratoires Servier
Highlights of The Sinus Bradycardia Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Atropine
- Isoproterenol
- Aminophylline
- Ephedrin
- Scopolamine
- Pacemaker
- Implantable Cardioverter Defibrillator
- By Application:
- Sinus Cardiac arrest
- Sinus Atrial Block
- Sinus Node Syndrome
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sinus Bradycardia Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sinus Bradycardia is a heart rhythm abnormality that can be caused by a number of factors, including:nn-Aortic stenosis (a narrowing of the aorta) u2013 This condition can cause decreased blood flow to the heart and lungs, which in turn can lead to low blood pressure and difficulty breathing. As a result, people with this condition are at an increased risk for developing sinus bradycardia.nn-A history of chest pain or other cardiac problems u2013 Sinus Bradycardia may be caused by an underlying problem with the heart that makes it difficult for the body to regulate its heartbeat.
Some of the major companies in the sinus bradycardia market are Abcam, Albany Molecular Research, Alchem International, Shree Pacetronix, Abbott Laboratories, Amgen, Livanova, C2 Pharma, CR Double-Crane, Fine Chemicals Corporation, Medtronic, Sorin Group, Biotronik, Nihon Kohden, Henry Schein, Hospira, Katsura Chemical, Luyin, Medarex, Merck, Boston Scientific, Nexus Pharmaceuticals, Pfizer, Phytex Australia, Oscor, ROLABO OUTSOURCING, Sanofi, Osypka Medical, Laboratoires Servier.
The sinus bradycardia market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sinus Bradycardia Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sinus Bradycardia Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sinus Bradycardia Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sinus Bradycardia Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sinus Bradycardia Market Size & Forecast, 2018-2028
4.5.1 Sinus Bradycardia Market Size and Y-o-Y Growth
4.5.2 Sinus Bradycardia Market Absolute $ Opportunity
Chapter 5 Global Sinus Bradycardia Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sinus Bradycardia Market Size Forecast by Type
5.2.1 Atropine
5.2.2 Isoproterenol
5.2.3 Aminophylline
5.2.4 Ephedrin
5.2.5 Scopolamine
5.2.6 Pacemaker
5.2.7 Implantable Cardioverter Defibrillator
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sinus Bradycardia Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sinus Bradycardia Market Size Forecast by Applications
6.2.1 Sinus Cardiac arrest
6.2.2 Sinus Atrial Block
6.2.3 Sinus Node Syndrome
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sinus Bradycardia Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sinus Bradycardia Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sinus Bradycardia Analysis and Forecast
9.1 Introduction
9.2 North America Sinus Bradycardia Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sinus Bradycardia Market Size Forecast by Type
9.6.1 Atropine
9.6.2 Isoproterenol
9.6.3 Aminophylline
9.6.4 Ephedrin
9.6.5 Scopolamine
9.6.6 Pacemaker
9.6.7 Implantable Cardioverter Defibrillator
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sinus Bradycardia Market Size Forecast by Applications
9.10.1 Sinus Cardiac arrest
9.10.2 Sinus Atrial Block
9.10.3 Sinus Node Syndrome
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sinus Bradycardia Analysis and Forecast
10.1 Introduction
10.2 Europe Sinus Bradycardia Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sinus Bradycardia Market Size Forecast by Type
10.6.1 Atropine
10.6.2 Isoproterenol
10.6.3 Aminophylline
10.6.4 Ephedrin
10.6.5 Scopolamine
10.6.6 Pacemaker
10.6.7 Implantable Cardioverter Defibrillator
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sinus Bradycardia Market Size Forecast by Applications
10.10.1 Sinus Cardiac arrest
10.10.2 Sinus Atrial Block
10.10.3 Sinus Node Syndrome
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sinus Bradycardia Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sinus Bradycardia Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sinus Bradycardia Market Size Forecast by Type
11.6.1 Atropine
11.6.2 Isoproterenol
11.6.3 Aminophylline
11.6.4 Ephedrin
11.6.5 Scopolamine
11.6.6 Pacemaker
11.6.7 Implantable Cardioverter Defibrillator
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sinus Bradycardia Market Size Forecast by Applications
11.10.1 Sinus Cardiac arrest
11.10.2 Sinus Atrial Block
11.10.3 Sinus Node Syndrome
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sinus Bradycardia Analysis and Forecast
12.1 Introduction
12.2 Latin America Sinus Bradycardia Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sinus Bradycardia Market Size Forecast by Type
12.6.1 Atropine
12.6.2 Isoproterenol
12.6.3 Aminophylline
12.6.4 Ephedrin
12.6.5 Scopolamine
12.6.6 Pacemaker
12.6.7 Implantable Cardioverter Defibrillator
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sinus Bradycardia Market Size Forecast by Applications
12.10.1 Sinus Cardiac arrest
12.10.2 Sinus Atrial Block
12.10.3 Sinus Node Syndrome
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sinus Bradycardia Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sinus Bradycardia Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sinus Bradycardia Market Size Forecast by Type
13.6.1 Atropine
13.6.2 Isoproterenol
13.6.3 Aminophylline
13.6.4 Ephedrin
13.6.5 Scopolamine
13.6.6 Pacemaker
13.6.7 Implantable Cardioverter Defibrillator
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sinus Bradycardia Market Size Forecast by Applications
13.10.1 Sinus Cardiac arrest
13.10.2 Sinus Atrial Block
13.10.3 Sinus Node Syndrome
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sinus Bradycardia Market: Competitive Dashboard
14.2 Global Sinus Bradycardia Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Albany Molecular Research
14.3.3 Alchem International
14.3.4 Shree Pacetronix
14.3.5 Abbott Laboratories
14.3.6 Amgen
14.3.7 Livanova
14.3.8 C2 Pharma
14.3.9 CR Double-Crane
14.3.10 Fine Chemicals Corporation
14.3.11 Medtronic
14.3.12 Sorin Group
14.3.13 Biotronik
14.3.14 Nihon Kohden
14.3.15 Henry Schein
14.3.16 Hospira
14.3.17 Katsura Chemical
14.3.18 Luyin
14.3.19 Medarex
14.3.20 Merck
14.3.21 Boston Scientific
14.3.22 Nexus Pharmaceuticals
14.3.23 Pfizer
14.3.24 Phytex Australia
14.3.25 Oscor
14.3.26 ROLABO OUTSOURCING
14.3.27 Sanofi
14.3.28 Osypka Medical
14.3.29 Laboratoires Servier
